VUF 5681 dihydrobromide

Pricing Availability Delivery Time Qty
Cat.No. 2493 - VUF 5681 dihydrobromide | C11H19N3.2HBr | CAS No. 639089-06-8
Description: Potent H3 receptor silent antagonist
Chemical Name: 4-[3-(1H-Imidazol-4-yl)propyl]piperidine dihydrobromide
Purity: ≥98% (HPLC)
Datasheet
Citations
Literature

Biological Activity

Potent histamine H3 receptor silent antagonist (pKi = 8.35).

Technical Data

M. Wt 355.11
Formula C11H19N3.2HBr
Storage Desiccate at RT
Purity ≥98% (HPLC)
CAS Number 639089-06-8
PubChem ID 53440140
InChI Key YFFVIGXPKWSZHW-UHFFFAOYSA-N
Smiles Br.Br.C(CC1CCNCC1)CC1=CNC=N1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 35.51 100
water 35.51 100

Preparing Stock Solutions

The following data is based on the product molecular weight 355.11. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 2.82 mL 14.08 mL 28.16 mL
5 mM 0.56 mL 2.82 mL 5.63 mL
10 mM 0.28 mL 1.41 mL 2.82 mL
50 mM 0.06 mL 0.28 mL 0.56 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets

Safety Datasheet

References

References are publications that support the products' biological activity.

Kitbunnadaj et al (2004) Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H3 receptor agonist. J.Med.Chem. 47 2414 PMID: 15115383

Leurs et al (2005) The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat.Rev.Drug Discov. 4 107 PMID: 15665857

Moreno-Delgado et al (2006) Constitutive activity of H3 autoreceptors modulates histamine synthesis in rat brain through the cAMP/PKA pathway. Neuropharmacology 51 517 PMID: 16769092


If you know of a relevant reference for VUF 5681 dihydrobromide, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Histamine H3 Receptor Antagonists

Keywords: VUF 5681 dihydrobromide, supplier, Potent, H3, receptor, silent, antagonists, Receptors, Histamine, histaminergic, VUF5681, dihydrobromide, Histamine, H3, Receptors, Histamine, H3, Receptors, Tocris Bioscience

Citations for VUF 5681 dihydrobromide

Citations are publications that use Tocris products.

Currently there are no citations for VUF 5681 dihydrobromide. Do you know of a great paper that uses VUF 5681 dihydrobromide from Tocris? If so please let us know.

Commented out for usability testing

Reviews

TODO: Add Reviews

Literature in this Area

GPCR

GPCR Product Listing

A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:

  • Rhodopsin-like Receptors
  • Secretin-like Receptors
  • Glutamate Receptors
  • Frizzled Receptors
  • GPCR Signaling
Histamine Receptors

Histamine Receptors Scientific Review

Written by Iwan de Esch and Rob Leurs, this review provides a synopsis of the different histamine receptor subtypes and the ligands that act upon them; compounds available from Tocris are listed.

Alzheimer's

Alzheimer's Poster

Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.

Asthma

Asthma Poster

Asthma is one of the most common chronic diseases in the world, affecting over 300 million people. This poster highlights key pathways and new therapies used to treat the condition, including those currently in clinical development.

Pathways for VUF 5681 dihydrobromide

Protocols

TODO: Add Protocols